02/19
Headlines

Finance

Morning Buzz : SandRidge Energy, Inc. (NYSE:SD), MannKind Corp. (NASDAQ:MNKD), Copart, Inc. (NASDAQ:CPRT), EMC Corporation (NYSE:EMC), National Instruments Corporation (NASDAQ:NATI)

Colin Pettis03 mins

On Oct. 15, SandRidge Energy, Inc. (NYSE:SD) announced that its Board of Directors has declared a $3.50 per share semi-annual dividend on its shares of 7.0% Convertible Perpetual Preferred Stock that will be paid in cash on November 15, 2014 to holders of record on November 1, 2014. SandRidge Energy, Inc. (NYSE:SD) belongs to Basic…

Read More

Trader’s Watch List : Alibaba Group Holding Ltd (NYSE:BABA), International Rectifier Corporation (NYSE:IRF), Aware, Inc. (NASDAQ:AWRE), Escalade Inc. (NASDAQ:ESCA), Norcraft Companies, Inc. (NYSE:NCFT

Chris Lewis03 mins

On Oct 17, The fourth annual Aliyun Worldwide Developer Conference (AWDC) hosted by Alibaba Group Holding Ltd (NYSE:BABA) Cloud Computing (AliCloud) concluded today and attracted more than 10,000 developers and partners from around the world for wide-ranging discussions focused on cloud security, cloud computing platforms, cloud migration and applications. The event also provided opportunities for…

Read More

News Buzz : Walgreen Co. (NYSE:WAG), The Walt Disney Company (NYSE:DIS), MSA Safety Incorporated (NYSE:MSA), NASB Financial, Inc. (NASDAQ:NASB), Digital Ally (NASDAQ:DGLY)

Adam Keintzel02 mins

Walgreen Co. (NYSE:WAG) challenged the version of events presented by its former Chief Financial Officer Wade Miquelon in a defamation lawsuit, saying in a court motion the former executive was responsible for the disappointing financial forecast that preceded his departure. Walgreen Co. (NYSE:WAG) belongs to Services sector. Its net profit margin is 2.50% and weekly…

Read More

Biotech Stock News: Prosensa Starts Rolling NDA Submission, Stock Reacts

Richard Atkins02 mins

Prosensa Holding N.V. (RNA) announced that it has initiated the process of rolling submission of a new drug application (NDA) to the FDA for its lead candidate, drisapersen, for the treatment of Duchenne muscular dystrophy (DMD). Drisapersen has Breakthrough Therapy Designation in the U.S. Moreover, the fast track status for drisapersen has made Prosensa eligible…

Read More